Applications of lipid nanoparticles in gene therapy

A del Pozo-Rodriguez, MÁ Solinís… - European Journal of …, 2016 - Elsevier
Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have been
recognized, among the large number of non-viral vectors for gene transfection, as an …

[HTML][HTML] Nucleic acid-based therapy for brain cancer: Challenges and strategies

Z Zhang, J Conniot, J Amorim, Y Jin, R Prasad… - Journal of Controlled …, 2022 - Elsevier
Nucleic acid-based therapy emerges as a powerful weapon for the treatment of tumors
thanks to its direct, effective, and lasting therapeutic effect. Encouragingly, continuous …

Short-and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy

A del Pozo-Rodríguez, MA Solinís, AR Gascón… - European Journal of …, 2009 - Elsevier
Most studies in gene therapy are focused on developing more efficient non-viral vectors,
ignoring their stability, even though physically and chemically stable vectors are necessary …

Cholesterol modified self-assemblies and their application to nanomedicine

F Ercole, MR Whittaker, JF Quinn, TP Davis - Biomacromolecules, 2015 - ACS Publications
Cholesterol is a ubiquitous molecule in biological systems, and in particular plays various
important roles in mammalian cellular processes. The presence of cholesterol is integral to …

Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression …

X Luan, K Rahme, Z Cong, L Wang, Y Zou, Y He… - European Journal of …, 2019 - Elsevier
Small interfering RNA (siRNA) has recently illustrated therapeutic potential for malignant
disorders. However, the clinical application of siRNA-based therapeutics is significantly …

Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration

A del Pozo-Rodríguez, D Delgado, MÁ Solinís… - International journal of …, 2010 - Elsevier
Naked plasmid DNA is a powerful tool for gene therapy, but it is rapidly eliminated from the
circulation after intravenous administration. Therefore, the development of optimized DNA …

[HTML][HTML] Non-viral delivery systems in gene therapy

AR Gascón, A del Pozo-Rodríguez… - Gene therapy-tools and …, 2013 - intechopen.com
Recent advances in molecular biology combined with the culmination of the Human
Genome Project [1] have provided a genetic understanding of cellular processes and …

Multifunctional imaging nanoprobes

PA Jarzyna, A Gianella, T Skajaa… - Wiley …, 2010 - Wiley Online Library
Multifunctional imaging nanoprobes have proven to be of great value in the research of
pathological processes, as well as the assessment of the delivery, fate, and therapeutic …

Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: formulating the solution

AM O'Mahony, BMDC Godinho, JF Cryan… - Journal of …, 2013 - Elsevier
The application of gene and RNAi-based therapies to the central nervous system (CNS), for
neurological and neurodegenerative disease, offers immense potential. The issue of …

Cytotoxicity and in vivo tissue compatibility of poly (amidoamine) with pendant aminobutyl group as a gene delivery vector

L Peng, Y Gao, YN Xue, SW Huang, RX Zhuo - Biomaterials, 2010 - Elsevier
To design successful polymeric gene delivery vehicles with good biocompatibility and highly
efficient gene transfer ability is one of the great scientific challenges in modern gene …